LawPlayer
My bookmarks
Source

Commission Implementing Regulation (EU) 2023/463 of 3 March 2023 authorising the placing on the market of bovine milk osteopontin as a novel food and amending Implementing Regulation (EU) 2017/2470 (Text with EEA relevance)

Commission Implementing Regulation (EU) 2023/463 of 3 March 2023 authorising the placing on the market of bovine milk osteopontin as a novel food and amending Implementing Regulation (EU) 2017/2470 (Text with EEA relevance)

Implementing Regulation (EU) 2023/463 · Regulation · 5 articles

Data as of 2026-07-04 · Compiled from an official source version. Later amendments or repeals may not be reflected; the official text prevails. · Read the official text ↗

Article 1

Open ↗

1.   Bovine milk osteopontin is authorised to be placed on the market within the Union. Bovine milk osteopontin shall be included in the Union list of novel foods set out in Implementing Regulation (EU) 2017/2470. 2.   The Annex to Implementing Regulation (EU) 2017/2470 is amended in accordance with the Annex to this Regulation.

Article 2

Open ↗

Only the company Arla Foods Ingredients Group P/S  ( 8 ) is authorised to place on the market within the Union the novel food referred to in Article 1, for a period of five years from 26 March 2023, unless a subsequent applicant obtains an authorisation for that novel food without reference to the scientific data protected pursuant to Article 3 or with the agreement of Arla Foods Ingredients Group P/S.

Article 3

Open ↗

The scientific data contained in the application file and fulfilling the conditions laid down in Article 26(2) of Regulation (EU) 2015/2283 shall not be used for the benefit of a subsequent applicant for a period of five years from the date of entry into force of this Regulation without the agreement of Arla Foods Ingredients Group P/S.

Article 4

Open ↗

This Regulation shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union.

Supplementary provisions

ANNEXSupplementary provisions

Open ↗

ANNEX The Annex to Implementing Regulation (EU) 2017/2470 is amended as follows: (1) In Table 1 (Authorised novel foods), the entry on ‘Bovine milk Osteopontin’ is inserted: Authorised novel food Conditions under which the novel food may be used Additional specific labelling requirements Other requirements Data Protection ‘Bovine milk osteopontin Specified food category Maximum levels The designation of the novel food on the labelling of the foodstuffs containing it shall be ‘Bovine milk Osteopontin’.   Authorised on 26 March 2023. This inclusion is based on proprietary scientific evidence and scientific data protected in accordance with Article 26 of Regulation (EU) 2015/2283. Applicant: Arla Foods Ingredients Group P/S., Sønderhøj 10-12 8260 Viby J Denmark. During the period of data protection, the novel food Bovine milk osteopontin is authorised for placing on the market within the Union only by Arla Foods Ingredients Group P/S., unless a subsequent applicant obtains authorisation for the novel food without reference to the proprietary scientific evidence or scientific data protected in accordance with Article 26 of Regulation (EU) 2015/2283 or with the agreement of Arla Foods Ingredients Group P/S. End date of the data protection: 26 March 2028. Infant formula as defined in Regulation (EU) No 609/2013  ( *1 ) 151 mg/L in the final product ready for use, marketed as such or reconstituted as instructed by the manufacturer Follow-on formula as defined in Regulation (EU) No 609/2013  ( *1 ) 151 mg/L in the final product ready for use, marketed as such or reconstituted as instructed by the manufacturer Milk-based drinks intended for young children 151 mg/L in the final product ready for use, marketed as such or reconstituted as instructed by the manufacturer (2) in Table 2 (Specifications), the following entry ‘Bovine milk osteopontin’ is inserted: Authorised Novel Food Specification ‘ Bovine milk osteopontin Description Bovine milk osteopontin is isolated from pasteurised or microfiltered bovine whey or milk by ion exchange chromatography, ultrafiltration to remove low molecular weight components and spray drying. During this filtration steps lactose and whey proteins predominantly alpha-lactalbumin and beta lactoglobulin are removed. Characteristics/Composition Protein % as is (N × 6,38): 76,5–80,5 Bovine milk osteopontin (bmOPN) (% of protein): ≥ 84,5 Full-length bmOPN (MW 33,9 kDa) (% of bmOPN): ≥ 15 N-terminal fragment bmOPN (MW 19,8 kDa) (% of bmOPN): ≥ 70 Other milk protein (% of protein): ≤ 14,5 Moisture: < 9,5 % Lactose: ≤ 1,0 % Fat: ≤ 1,0 % Ash: ≤ 11 % Insolubility index (mL) ≤ 1,0 Heavy metals Lead: < 0,05 mg/kg Cadmium: < 0,05 mg/kg Mercury: < 0,05 mg/kg Arsenic: < 0,5 mg/kg Aflatoxin M1 < 0,1 μg/kg Microbiological criteria Total plate count (30 °C) (CFU/g): ≤ 5 000 Mould/yeast (CFU/g): ≤ 100 Bacillus cereus (CFU/g): < 50 Sulfur-reducing Clostridia (CFU/g): < 10 Staphylococcus aureus : Not detected in 1 g Enterobacteriaceae (CFU/g): < 10 Salmonella spp.: Not detected in 25 g CFU: Colony Forming Units’ ( *1 )   Without prejudice to the requirements of Regulation (EU) No 609/2013 and Regulation (EU) 2016/127.’

Other acts of the same type
Commission Implementing Regulation (EU) 2024/2777 of 31 October 2024 concerning the non-renewal of approval of the active substance tritosulfuron, in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council, and amending Commission Implementing Regulation (EU) No 540/2011Commission Implementing Regulation (EU) 2024/2781 of 31 October 2024 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances 8-hydroxyquinoline, aminopyralid, azoxystrobin, Candida oleophila strain O, chlorantraniliprole, fluroxypyr, imazalil, kresoxim-methyl, metobromuron, oxyfluorfen, Paecilomyces fumosoroseus strain FE 9901, tefluthrin and terbuthylazineCommission Implementing Regulation (EU) 2024/2794 of 31 October 2024 amending Implementing Regulation (EU) 2021/1378 as regards the recognition of certain control bodies in accordance with Article 46 of Regulation (EU) 2018/848 of the European Parliament and of the Council as competent to carry out controls and issue organic certificates in third countries for the purpose of imports of organic products into the UnionCommission Implementing Regulation (EU) 2024/2806 of 31 October 2024 concerning the non-renewal of the approval of the active substance metribuzin, in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council, and amending Commission Implementing Regulation (EU) No 540/2011 and Commission Implementing Regulation (EU) 2015/408Commission Delegated Regulation (EU) 2025/65 of 31 October 2024 amending Delegated Regulation (EU) 2019/2123 as regards the conditions under which a separate Common Health Entry Document is submitted for consignments leaving a border control post for a control point where identity and physical checks are to be performedCommission Delegated Regulation (EU) 2025/296 of 31 October 2024 supplementing Regulation (EU) 2023/1114 of the European Parliament and of the Council with regard to regulatory technical standards specifying the procedure for the approval of a crypto-asset white paperCommission Delegated Regulation (EU) 2025/297 of 31 October 2024 supplementing Regulation (EU) 2023/1114 of the European Parliament and of the Council with regard to regulatory technical standards specifying the conditions for the establishment and functioning of consultative supervisory collegesCommission Delegated Regulation (EU) 2025/298 of 31 October 2024 supplementing Regulation (EU) 2023/1114 of the European Parliament and of the Council with regard to regulatory technical standards specifying the methodology to estimate the number and value of transactions associated to uses of asset-referenced tokens and of e-money tokens denominated in a currency that is not an official currency of a Member State as a means of exchangeCommission Delegated Regulation (EU) 2025/299 of 31 October 2024 supplementing Regulation (EU) 2023/1114 of the European Parliament and of the Council on markets in crypto-assets with regard to regulatory technical standards on continuity and regularity in the performance of crypto-asset servicesCommission Delegated Regulation (EU) 2025/303 of 31 October 2024 supplementing Regulation (EU) 2023/1114 of the European Parliament and of the Council with regard to regulatory technical standards specifying the information to be included by certain financial entities in the notification of their intention to provide crypto-asset servicesCommission Implementing Regulation (EU) 2025/304 of 31 October 2024 laying down implementing technical standards for the application of Regulation (EU) 2023/1114 of the European Parliament and of the Council with regard to standard forms, templates and procedures for the notification by certain financial entities of their intention to provide crypto-asset servicesCommission Delegated Regulation (EU) 2025/305 of 31 October 2024 supplementing Regulation (EU) 2023/1114 of the European Parliament and of the Council with regard to regulatory technical standards specifying the information to be included in an application for authorisation as a crypto-asset service provider

Source: EUR-Lex (Publications Office of the EU), © European Union, reuse permitted under Commission Decision 2011/833/EU.

Contents

What to look at next